LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | PD184352 | 0.37 | uM | LJP5 | 72 | hr | 513 | 2140 | 10362 | 0.2067 | 0.3895 |
MCF 10A | PD184352 | 1.11 | uM | LJP5 | 72 | hr | 513 | 1543 | 10362 | 0.1490 | 0.2875 |
MCF 10A | PD184352 | 3.33 | uM | LJP5 | 72 | hr | 513 | 1165 | 10362 | 0.1124 | 0.2079 |
MCF 10A | PD184352 | 10 | uM | LJP5 | 72 | hr | 513 | 781 | 10362 | 0.0754 | 0.1018 |
MCF 10A | PLX-4720 | 0.04 | uM | LJP5 | 72 | hr | 513 | 10627 | 10362 | 1.0254 | 1.0115 |
MCF 10A | PLX-4720 | 0.12 | uM | LJP5 | 72 | hr | 513 | 10983 | 10362 | 1.0602 | 1.0270 |
MCF 10A | PLX-4720 | 0.37 | uM | LJP5 | 72 | hr | 513 | 11131 | 10362 | 1.0743 | 1.0333 |
MCF 10A | PLX-4720 | 1.11 | uM | LJP5 | 72 | hr | 513 | 11521 | 10362 | 1.1122 | 1.0495 |
MCF 10A | PLX-4720 | 3.33 | uM | LJP5 | 72 | hr | 513 | 10721 | 10362 | 1.0349 | 1.0157 |
MCF 10A | PLX-4720 | 10 | uM | LJP5 | 72 | hr | 513 | 7135 | 10362 | 0.6888 | 0.8350 |
MCF 10A | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 513 | 9294 | 10473 | 0.8875 | 0.9459 |
MCF 10A | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 513 | 8925 | 10473 | 0.8523 | 0.9278 |
MCF 10A | Lapatinib | 0.37 | uM | LJP6 | 72 | hr | 513 | 8542 | 10473 | 0.8157 | 0.9085 |
MCF 10A | Lapatinib | 1.11 | uM | LJP6 | 72 | hr | 513 | 6980 | 10473 | 0.6666 | 0.8219 |
MCF 10A | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 3620 | 10473 | 0.3456 | 0.5665 |
MCF 10A | Lapatinib | 10 | uM | LJP6 | 72 | hr | 513 | 770 | 10473 | 0.0735 | 0.0953 |
MCF 10A | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 513 | 9497 | 10473 | 0.9067 | 0.9553 |
MCF 10A | Sirolimus | 0.12 | uM | LJP6 | 72 | hr | 513 | 10290 | 10473 | 0.9828 | 0.9917 |
MCF 10A | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 513 | 10033 | 10473 | 0.9580 | 0.9803 |
MCF 10A | Sirolimus | 1.11 | uM | LJP6 | 72 | hr | 513 | 10098 | 10473 | 0.9641 | 0.9832 |
MCF 10A | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 513 | 10271 | 10473 | 0.9808 | 0.9909 |
MCF 10A | Sirolimus | 10 | uM | LJP6 | 72 | hr | 513 | 9940 | 10473 | 0.9489 | 0.9756 |
MCF 10A | ZSTK474 | 0.04 | uM | LJP6 | 72 | hr | 513 | 7992 | 10473 | 0.7632 | 0.8793 |
MCF 10A | ZSTK474 | 0.12 | uM | LJP6 | 72 | hr | 513 | 5213 | 10473 | 0.4976 | 0.7027 |
MCF 10A | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 513 | 3122 | 10473 | 0.2980 | 0.5140 |